Cart
sales@molnova.com
Home - Products - Cell Cycle/DNA Damage - DNA/RNA Synthesis - OPC 21268

OPC 21268

CAS No. 131631-89-5

OPC 21268 ( OPC-21268; OPC21268; OPC 21268 )

Catalog No. M17244 CAS No. 131631-89-5

OPC 21268 is a non-peptide Arginine vasopressin(AVP) Receptor V antagonist.

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 47 In Stock
5MG 72 In Stock
10MG 97 In Stock
25MG 164 In Stock
50MG 230 In Stock
100MG 398 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Group Booking Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    OPC 21268
  • Note
    Research use only, not for human use.
  • Brief Description
    OPC 21268 is a non-peptide Arginine vasopressin(AVP) Receptor V antagonist.
  • Description
    OPC-21268 is a vasopressin 1 receptor antagonist potentially for the treatment of heart failure and hypertension.
  • Synonyms
    OPC-21268; OPC21268; OPC 21268
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    DNA/RNA Synthesis
  • Recptor
    Vasopressin receptor 1
  • Research Area
    Cardiovascular Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    131631-89-5
  • Formula Weight
    449.55
  • Molecular Formula
    C26H31N3O4
  • Purity
    98%
  • Solubility
    DMSO : 50 mg/mL. 111.22 mM;
  • SMILES
    CC(=O)NCCCOC1=CC=C(C=C1)C(=O)N2CCC(CC2)N3C(=O)CCC4=CC=CC=C43
  • Chemical Name
    N-(3-(4-(4-(2-oxo-3,4-dihydroquinolin-1(2H)-yl)piperidine-1-carbonyl)phenoxy)propyl)acetamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Yamamura Y，etal.PC-21268, an orally effective, nonpeptide vasopressin V1 receptor antagonist.Science. 1991 Apr 26;252(5005):572-4.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Tetrahydrouridine

    Tetrahydrouridine (THU) is a multidrug resistance modulator. It can be used in cancer treatment to make tumor cells more sensitive to radiation therapy.

  • HALOFUGINONE LACTATE

    HALOFUGINONE LACTATE is a halogenated derivative of febrifugine, a natural quinazolinone-containing compound found in the Chinese herb D. febrifuga.Halofuginone inhibits prolyl-tRNA synthetase in an ATP-dependent manner with a Ki of 18.3 nM.?Halofuginone is a specific inhibitor of type-I collagen synthesis and attenuates osteoarthritis (OA) by inhibition of TGF-β activityhalofuginone (HF), a widely studied derivative of febrifugine, inhibits the development of T(H)17-driven autoimmunity in a mouse model of multiple sclerosis by activating the amino acid response (AAR) pathway.?HF binds glutamyl-prolyl-tRNA synthetase (EPRS), inhibiting prolyl-tRNA synthetase activity;?this inhibition is reversed by the addition of exogenous proline or EPRS.

  • Deoxyshikonin

    Deoxyshikonin may be a new drug candidate for wound healing and treatment of lymphatic diseases.

Sign In Join Free